Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a minor page version update. It reflects a small update to the page's metadata rather than any changes to study content or results.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe footer now displays the updated frontend revision (v3.5.4), replacing the prior revision (v3.5.3), indicating a frontend version update.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study details.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now displays Revision: v3.5.2 and no longer shows Revision: v3.5.0.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check93 days agoChange DetectedNew page revision notes and version identifiers were added, including Revision: v3.4.3 with date 2026-03-05 and additional dates 2027-02, 2026-03-03, and 2026-03. The previous revision v3.4.2 is listed under deletions.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.